IMJUDO 20 mg/ml concentrate for solution for infusion
*Company:
AstraZeneca Pharmaceuticals (Ireland) DACStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 27 February 2024
File name
20240216 SPC IE MT Imjudo Uveitis and immune mediated arthritis ONC 24 0003.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 27 February 2024
File name
20240216 Package Leaflet IE MT Imjudo Uveitis and immune mediated arthritis ONC 24 0004.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
File name
Imjudo Patient Card.pdf
Reasons for updating
- Add New Doc
Updated on 02 January 2024
File name
20231214 SPC IE MT Imjudo Paediatric Update ONC 23 0047.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 27 September 2023
File name
20230807 Package Leaflet IE MT Imjudo Solution for Infusion 20 mg-ml Postcode update ONC 23 0035.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
New package leaflet for a new product
Updated on 27 September 2023
File name
20230804 SPC IE MT Imjudo Solution for Infusion 20 mg-ml HIMALAYA and POSEIDON ONC 23 0034.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New SmPC for a new product